Recurrent Miscarriage Clinical Trial
— SiMOfficial title:
Pilot Randomised Controlled Trial of the Effect of Endometrial Scratch in Recurrent Miscarriage on Pregnancy Outcomes
Verified date | January 2019 |
Source | University Hospitals Coventry and Warwickshire NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There is increasing amount of evidence which suggests that miscarriage is related to a
primary endometrial problem. Recent cochrane meta-analysis (March 2015) has proven that
endometrial scratch improves live birth in women who underwent IVF.
The aim of the study is to find out if scratch of the endometrium prevents recurrent
miscarriage.
Status | Completed |
Enrollment | 109 |
Est. completion date | September 1, 2017 |
Est. primary completion date | June 26, 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: 1. Provision of written informed consent 2. Actively trying for a pregnancy Exclusion Criteria: 1. No active treatment in pregnancy 2. Inherited or acquired thrombophilia 3. Medical conditions- diabetes,hypertension,thyroid disorders 4. inability to tolerate internal examinations 5. uterine anomalies 6. Previous entry or randomisation in the present trial |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University Hospitals of Coventry and Warwickshire NHS Trust | Coventry | West Midlands |
Lead Sponsor | Collaborator |
---|---|
University Hospitals Coventry and Warwickshire NHS Trust | University of Warwick |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Live Birth Rate after 24 weeks of gestation | from the recruitment of the first patient up to 12 months after the recruitment of last patient. the live birth rate of all the pregnant patients in the study who delivered after 24 weeks will be included in the outcome. | ||
Secondary | Miscarriage until 23+6 weeks of gestation | from the recruitment of the first patient and up to 12 months after the recruitment of last patient. the outcomes of all the pregnant patients in the study who delivered up to 23+6 weeks will be included in the outcome. | ||
Secondary | Pregnancy complications | Such as SGA(small for gestational age),PET( Pre-eclamptic toxaemia),Abruption, Placenta Praevia, Placenta accreta and Preterm delivery | from the recruitment of the first patient and up to 12 months after the recruitment of last patient. The patients who delivered after 24 weeks with a live birth will be included in the outcome and the described outcomes will be measured | |
Secondary | Acceptability of the intervention | To guide future trial set up | Patient questionnaire will be issued at the time of randomisation. the returned forms up to 4 weeks after randomisation will be analysed and reported. this will be helpful for assessing the patients tolerability of the procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01419392 -
Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages
|
Phase 4 | |
Completed |
NCT00193674 -
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
|
Phase 3 | |
Completed |
NCT06001060 -
Distinct Alterations in Gut Microbiota Composition Among Women of Reproductive Age With Elevated Homocysteine Levels.
|
||
Recruiting |
NCT05034250 -
Iron Status in Female Infertility and Recurrent Miscarriage
|
||
Recruiting |
NCT02303171 -
Use of Warfarin After the First Trimester in Pregnant Women With APS
|
Phase 4 | |
Completed |
NCT02305420 -
EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage
|
Phase 4 | |
Recruiting |
NCT05824897 -
The Cohort Study of the Correlation Between Serum 25(OH)D Level and Pregnancy Outcome
|
||
Completed |
NCT03023137 -
Walking and Dietary Modification for Recurrent Early Miscarriages
|
N/A | |
Not yet recruiting |
NCT03132779 -
Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion
|
Phase 1 | |
Completed |
NCT02184741 -
A Study of the Efficacy and Safety of GB-0998 in Patients With Unexplained Recurrent Miscarriage
|
Phase 3 | |
Active, not recruiting |
NCT02156063 -
A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
|
Phase 2 | |
Recruiting |
NCT03902912 -
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
|
Phase 3 | |
Not yet recruiting |
NCT03209063 -
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
|
||
Completed |
NCT03970954 -
Low-dose Interleukin-2 in Women With Unexplained Miscarriages
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06249230 -
The Analysis of Risk Factors for Recurrent Pregnancy Loss and Prediction of Pregnancy Loss Risk
|
||
Recruiting |
NCT05725512 -
Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
|
Phase 4 | |
Recruiting |
NCT05267678 -
Nutritional Deficiency and Recurrent Miscarriage
|
||
Completed |
NCT02694367 -
Expression of EPK in Recurrent Miscarriage
|
N/A | |
Completed |
NCT02504281 -
Study on the Association Between SXCI and RM and the Possible Genetic Mechanism
|
||
Completed |
NCT01608347 -
Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies
|
Phase 4 |